Selank 10 mg | Research Compound
Selank is a synthetic heptapeptide analogue of the naturally occurring tetrapeptide tuftsin, modified to include a glyproline sequence for increased stability. It is primarily studied for its anxiolytic (anti-anxiety) properties and its ability to modulate the metabolism of serotonin and other neurotransmitters in the brain. Unlike traditional sedatives, Selank is investigated for its potential to provide regulatory effects on the central nervous system without inducing drowsiness or cognitive impairment.
Findings from early-stage clinical trials have reported:
- Reductions in anxiety-related behaviors and stress markers observed in experimental subjects
- Increased expression of Brain-Derived Neurotrophic Factor (BDNF) reported in hippocampal research
- Modulation of the GABAergic system and alterations in serotonin metabolism noted in-vivo
- Enhanced immune system signaling, specifically relating to cytokine balance, observed in research cohorts
Researchers study Selank to investigate the intersection of the nervous and immune systems. Its ability to act as a regulatory agent makes it a valuable tool for exploring neuroprotection, cognitive enhancement, and the biological response to chronic stress. It is a focal point for research into the management of neurochemical imbalances and the preservation of cognitive function during environmental stressors.
Available Formats:
This compound is available in a 9ml premixed spray bottle, providing a stable solution for precise administration in research settings.
Used solely for in vitro experiments and cannot be:
- Used in clinical trials involving humans
- Administered to humans as part of an experiment or investigation
- Supplied to another party for human investigational use
| IDENTIFICATION | |
| Product Name | Selank 10 mg |
| Catalogue Number | RP-SELANK-01 |
| CAS Number | 129954-34-3 |
| Molecular Weight (g/mol) | 751.9 g/mol |
| Molecular Formula | C33H57N11O9 |
| Peptide Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| PHYSICAL AND CHEMICAL PROPERTIES | |
| Active Ingredient | Selank |
| Appearance | White to off-white lyophilised powder |
| Melting Point | Not applicable (decomposes before melting) |
| ANALYTICAL AND QUALITY CONTROL | |
| Mass Spectrum | Conforms to specification |
| Structural Confirmation | Consistent with theoretical structure / sequence |
| RESEARCH USE AND SAFETY | |
| Caution | Handle using appropriate PPE and in compliance with relevant laboratory safety standards. |
| Intended Use | For laboratory research use only. Not for human or veterinary use. |
| Hazard Classification | Not classified as hazardous under GHS for research quantities |
| STORAGE, HANDLING AND STABILITY | |
| Storage Temperature, Opened | -20 °C, minimise freeze–thaw cycles |
| Storage Temperature, Unopened | -20 °C recommended for long-term storage |
| Shelf Life | 2 years unopened under recommended conditions |
| Reconstitution Stability | Stable for up to 28 days at 2–8 °C in aqueous solution under sterile conditions |
Certificate of Analysis – Selank (99% Purity Verified)
| COMPOUND IDENTIFICATION | |
| Product Name | Selank (10mg Spray) |
| Batch / Reference ID | SL101216 |
| Sample Form | White powder in glass vial |
| ANALYTICAL RESULTS | |
| Chemical Purity | 99% (Verified) |
| Measured Content | 10.42mg (± 0.05mg) |
| Test Method | HPLC (High-Performance Liquid Chromatography) |
| LABORATORY TESTING INFORMATION | |
| Analysis Period | 06 Feb 2026 – 10 Feb 2026 |
| Laboratory Order # | 100012232 |
| QUALITY ASSURANCE | |
| Quality Testing Standards | All River Peptides products undergo batch-level laboratory analysis to verify compound identity and confirm purity levels. Learn more on our Quality Testing & Purity Verification page. |
Related Products
